Pillstats
OTC · Solution · Oral

Codeine Phosphate And Guaifenesin

Brands: Codeine-Guaifenesin · Codeine Phosphate + Guaifenesin

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)5032
US makers6 labelers
Packages8
DEA / ScheduleCV

US acquisition costNADAC · per unit

Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.013$0.027$0.040$0.053Dec 2025Apr 2026Jul 2026
$0.046
Latest avg · Jul 22, 2026
+5%
Since Dec 17, 2025
6
Active US suppliers
50%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

10K20K31K41K2025 Q12025 Q22025 Q32025 Q42026 Q1
36K
Rx · 2026 Q1
5.3M
Units dispensed
+3%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Method Pharmaceuticals, LLCunknown2SUPPLYING
Westminster Pharmaceuticals, LLCunknown2SUPPLYING
Bryant Ranch Prepackrepackager1SUPPLYING
Proficient Rx LPunknown1SUPPLYING
A-S Medication Solutionsunknown1SUPPLYING
NuCare Pharmaceuticals, Inc.unknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Dec 12, 2017
    RECALLRecall (Class II): Codeine-Guaifenesin Oral Solution 10-100 mg/5 mL Antitussive Expectorant ,16 fl. oz. , Manufactured For: Method Pharmac…

    Microbial Contamination of Non-Sterile Products: potentially contamination with the bacteria Burkholderia cepacia — Recalling firm: Woodfield Pharmaceutical, LLC — Texas